Latest / Decera Clinical Education Oncology Podcast
Beyond BCMA: How GPRC5D-Targeted Therapy Fits into Multiple Myeloma Care Today
Treatment options for patients with multiple myeloma are rapidly evolving. In this podcast episode, Jesus Berdeja, MD, and Amrita Krishnan, MD, FCAP, discuss GPRC5D-directed treatment options for patients with relapsed/refractory multiple myeloma, with a focus on talquetamab, a GPRC5D-directed bispecific antibody. Topic areas covered include:
Clinical trial updates and discussion of how findings may translate into clinical practice and FDA approvals
Treatment sequencing and patient selection
Step-up dosing and what to expect in terms of toxicity management when using a GPRC5D-targeted therapy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.